Similar articles

• From studies of biochemical mechanism to novel biological mediators: prostaglandin endoperoxides, thromboxanes, and leukotrienes. Nobel Lecture, 8 December 1982.

  Samuelsson B. Samuelsson B. Biosci Rep. 1983 Sep;3(9):791-813. doi: 10.1007/BF01133779. Biosci Rep. 1983. PMID: 6315101 Review. No abstract available.
• Biologically active derivatives of fatty acids: prostaglandins, thromboxanes, and endoperoxides.

  Kuehl FA Jr, Humes JL, Beveridge GC, Van Arman CG, Egan RW. Kuehl FA Jr, et al. Inflammation. 1977 Dec;2(4):285-94. doi: 10.1007/BF00921008. Inflammation. 1977. PMID: 370001 Review.
• Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin.

  Moncada S, Vane JR. Moncada S, et al. Pharmacol Rev. 1978 Sep;30(3):293-331. Pharmacol Rev. 1978. PMID: 116251 Review. No abstract available.
• [Prostaglandins and inflammation (author's transl)].

  Famaey JP. Famaey JP. Rev Med Brux. 1981 Apr;2(4):451-3. Rev Med Brux. 1981. PMID: 7027404 French. No abstract available.
• [Prostaglandins and inflammation].

  Velo GP, Fracasso ME, Leone R. Velo GP, et al. G Ital Chemioter. 1979 Jan-Dec;26(1-2):85-90. G Ital Chemioter. 1979. PMID: 233424 Review. Italian. No abstract available.